1. Ganglions sentinelles et carcinome canalaire in situ.
- Author
-
Tunon de Lara, C., Fournier, M., and Macgrogan, G.
- Subjects
- *
DUCTAL carcinoma , *ADENOCARCINOMA , *BIOPSY , *CANCER cells , *METASTASIS - Abstract
The diagnosis of ductal carcinoma in situ (DCIS) using core biopsy (CB) does not ensure the absence of invasion on final excision. The risk of invasion and upstaging ranges from 8% to 42.7% in various studies. The role of sentinel lymph node biopsy in patients on CB of DCIS has been the subject of debate. Furthermore, SLN is not usually required in all cases of DCIS but may be indicated in such specific cases: 1) where mastectomy is performed; 2) with large lesions or palpable mass; 3) with high grade tumours; 4) and where the pathologist cannot rule out micro-invasion. Pure DCIS patients do have tumour positive findings, but a majority of these are isolated tumour cells (ITCs) or micro-metastases. SLN positive does not affect the outcomes of DCIS patients. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF